Quantcast

Latest Diabetic foot Stories

2010-05-26 16:11:00

ZUG, Switzerland and CANTON, Mass., May 26 /PRNewswire/ -- Organogenesis Switzerland GmbH will sponsor a symposium on Apligraf®, a bilayered living cellular construct for the treatment of chronic wounds and soft tissue repair, at the upcoming European Wound Management Association (EWMA) conference. This will be the first symposium ever held in Europe on the use of an allogeneic living cellular construct in the treatment of chronic wounds. At the symposium, titled...

2010-04-26 07:25:00

LOMBARD, Ill., April 26 /PRNewswire/ -- With over ten million diabetics in the U.S. alone and approximately 150,000 amputations performed yearly, inventor and American board-certified prosthetist John E. Rooney developed a custom-made ankle-foot orthosis with the trade name Ulcer Healing Orthosis(R) or UHO(R). The U.S. patented device helps to support the lower leg and foot, reducing mechanical stress on the bottom of the ulcerated foot. This allows blood flow to the ulceration, encouraging...

2010-04-15 07:00:00

ADDISON, Texas, April 15 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) announced today that the company will present clinical evidence at the 2010 joint annual meeting of the Symposium on Advanced Wound Care and the Wound Healing Society (SAWC/WHS) in Orlando, Florida, April 17-20. SAWC/WHS is the premier wound care educational program within this clinical field and is the largest annual gathering of wound care clinicians in the United States. More than 2,000 physicians,...

2010-03-23 09:34:00

ADDISON, Texas, March 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) announced that it sponsored a Wound Dressing Workshop at the 2010 Diabetic Foot Global Conference. Attendees of the Diabetic Foot Global Conference (DFCon) in Hollywood, California on March 20, 2010 participated in a hands-on workshop where they were trained in "best clinical practice" for Altrazeal(TM). Participants learned application techniques, clinical endpoints, and methods for treating different wound...

2010-03-17 12:52:00

LAKE CHARLES, La., March 17 /PRNewswire/ -- Everyone has heard of Botox being used to reduce the appearance of fine lines and wrinkles, but now the muscle-immobilizing treatment is moving to the opposite end of the body to get patients back on their feet. Craig Morton, MD, and Tyson Green, DPM, with the Center for Orthopaedics in Lake Charles, Louisiana, are successfully using Botox for patients with conditions ranging from diabetic foot ulcers to cerebral palsy. "Because of the...

2010-01-05 08:15:00

SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to launch a new premium advanced skin care product line to promote foot health and comfort for podiatry patients. Cardium's new MedPodium(TM) product line is an over-the-counter product portfolio for patients with the potential for foot disorders and ailments. MedPodium represents a new line of foot care products to broaden and complement Cardium's Excellagen topical gel product...

2009-12-16 11:10:00

SAN DIEGO, Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) The study titled, "A history of foot ulcer increases mortality among persons with...

2009-12-15 09:01:00

ROSH HA'AYIN, Israel, December 15 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. The FDA also cleared DermaSept, an Over-the-Counter version of the SilverStream product. EnzySurge is the developer of the DermaStream(R) product line. DermaStream...

2009-12-03 09:00:00

NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic Foot Care in New Delhi, India, November 22, 2009. Beike is China's leading stem cell research and regenerative medicine company. The conference, organized by the Indian Podiatry Association (IPA), aimed to help podiatrists and researchers with an interest in foot disease...

2009-12-01 07:30:00

FORT WORTH, Texas, Dec. 1 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that further positive case study data on CellerateRx®, the core product of the Wound Care Innovations, LLC operating subsidiary, was released at the recent 6(th) Annual High Risk Diabetic Foot Conference for VA Podiatrists and Healthcare Professional in Tempe, AZ. One of the Wound...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.